SO
LXRX icon

STRS Ohio’s Lexicon Pharmaceuticals LXRX Stock Holding History

STRS Ohio’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,700
Closed -$72K – 2285
2021
Q2 		$72K Sell
15,700
-103,100
-87% -$497K ﹤0.01% 2046
2021
Q1 		$697K Sell
118,800
-86,100
-42% -$596K ﹤0.01% 1424
2020
Q4 		$700K Sell
204,900
-108,400
-35% -$207K ﹤0.01% 1278
2020
Q3 		$451K Buy
313,300
+80,100
+34% +$143K ﹤0.01% 1393
2020
Q2 		$465K Buy
233,200
+70,400
+43% +$138K ﹤0.01% 1357
2020
Q1 		$317K Buy
162,800
+33,900
+26% +$101K ﹤0.01% 1426
2019
Q4 		$534K Buy
+128,900
New +$496K ﹤0.01% 1417
2017
Q1 		– Sell
-50,400
Closed -$748K – 1908
2016
Q4 		$697K Buy
50,400
+7,200
+17% +$116K ﹤0.01% 1126
2016
Q3 		$780K Sell
43,200
-11,500
-21% -$185K ﹤0.01% 951
2016
Q2 		$784K Sell
54,700
-3,400
-6% -$46.1K ﹤0.01% 938
2016
Q1 		$694K Buy
58,100
+57,744
+16,220% +$605K ﹤0.01% 1013
2015
Q4 		$4K Hold
356
– – ﹤0.01% 1896
2015
Q3 		$3K Hold
356
– – ﹤0.01% 1865
2015
Q2 		$2K Hold
356
– – ﹤0.01% 1854
2015
Q1 		$2K Hold
356
– – ﹤0.01% 1799
2014
Q4 		$2K Hold
356
– – ﹤0.01% 1732
2014
Q3 		$4K Hold
356
– – ﹤0.01% 1772
2014
Q2 		$4K Hold
356
– – ﹤0.01% 1684
2014
Q1 		$4K Hold
356
– – ﹤0.01% 1701
2013
Q4 		$4K Sell
356
-43
-11% -$684 ﹤0.01% 1727
2013
Q3 		$7K Hold
399
– – ﹤0.01% 1812
2013
Q2 		$6K Buy
+399
New +$6.06K ﹤0.01% 1821

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

STRS Ohio's LXRX Position: Q3 2021 in Review

STRS Ohio sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2021, closing a stake of 15,700 shares — an estimated $72K sold.

STRS Ohio first reported a position in LXRX in Q2 2013 and held it in 22 quarters. The position peaked at $784K in Q2 2016. 96 funds tracked by Wall St. Rank hold LXRX as of Q3 2021.

  • STRS Ohio reported no remaining Lexicon Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • STRS Ohio sold 15,700 Lexicon Pharmaceuticals shares in Q3 2021, an estimated $72K.
  • STRS Ohio first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • STRS Ohio's Lexicon Pharmaceuticals position peaked at $784K in Q2 2016.
  • 96 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2021.

Based on STRS Ohio's 13F filing for Q3 2021, filed 22 Oct 2021.